Compare ROP & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROP | IDXX |
|---|---|---|
| Founded | 1981 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.0B | 55.0B |
| IPO Year | 1992 | 1991 |
| Metric | ROP | IDXX |
|---|---|---|
| Price | $450.53 | $688.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 10 |
| Target Price | $600.23 | ★ $700.50 |
| AVG Volume (30 Days) | ★ 1.1M | 525.8K |
| Earning Date | 01-29-2026 | 02-02-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | 6.17 | ★ 21.65 |
| EPS | ★ 14.52 | 12.60 |
| Revenue | ★ $7,721,000,000.00 | $4,167,411,000.00 |
| Revenue This Year | $13.76 | $12.15 |
| Revenue Next Year | $8.74 | $8.72 |
| P/E Ratio | ★ $31.05 | $54.64 |
| Revenue Growth | ★ 13.95 | 8.39 |
| 52 Week Low | $435.42 | $356.14 |
| 52 Week High | $595.17 | $769.98 |
| Indicator | ROP | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 43.69 |
| Support Level | $442.00 | $676.06 |
| Resistance Level | $451.69 | $711.68 |
| Average True Range (ATR) | 6.64 | 14.57 |
| MACD | 1.50 | -3.48 |
| Stochastic Oscillator | 72.90 | 27.75 |
Roper Technologies is a holding company focused on acquiring, managing, and developing niche market-leading technology businesses. The company operates a decentralized business model whereby each portfolio company operates independently from the others. Roper positions itself as a free cash flow compounder, whereby excess free cash flow generated by its portfolio businesses is repatriated to the parent company, which is then utilized to acquire additional businesses. Presently, the company operates 30 distinct businesses with over three-fourths of the revenue coming from software products and over two-thirds of revenue coming from recurring and reoccurring sources.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.